NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 193 filers reported holding NOVAVAX INC in Q3 2015. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $810,000 | -20.4% | 1,471,886 | +165.9% | 0.00% | – |
| Q4 2018 | $1,018,000 | -10.7% | 553,644 | -8.7% | 0.00% | – |
| Q3 2018 | $1,140,000 | +30.3% | 606,539 | -7.1% | 0.00% | – |
| Q2 2018 | $875,000 | -7.1% | 652,931 | +45.6% | 0.00% | – |
| Q1 2018 | $942,000 | +182.9% | 448,572 | +67.2% | 0.00% | – |
| Q4 2017 | $333,000 | -50.4% | 268,345 | -54.4% | 0.00% | – |
| Q3 2017 | $671,000 | +25.0% | 588,671 | +26.0% | 0.00% | – |
| Q2 2017 | $537,000 | -42.4% | 467,347 | -35.9% | 0.00% | – |
| Q1 2017 | $933,000 | +40.5% | 728,790 | +38.3% | 0.00% | – |
| Q4 2016 | $664,000 | -59.6% | 526,995 | -33.2% | 0.00% | – |
| Q3 2016 | $1,643,000 | -54.0% | 789,413 | +60.8% | 0.00% | -100.0% |
| Q2 2016 | $3,568,000 | -2.8% | 490,862 | -31.0% | 0.00% | 0.0% |
| Q1 2016 | $3,669,000 | -34.0% | 710,923 | +7.3% | 0.00% | -50.0% |
| Q4 2015 | $5,562,000 | -21.9% | 662,851 | -34.2% | 0.00% | 0.0% |
| Q3 2015 | $7,120,000 | +211.7% | 1,007,242 | +391.2% | 0.00% | +100.0% |
| Q2 2015 | $2,284,000 | -26.2% | 205,045 | -45.2% | 0.00% | 0.0% |
| Q1 2015 | $3,093,000 | +114.9% | 373,967 | +54.1% | 0.00% | – |
| Q4 2014 | $1,439,000 | +152.5% | 242,680 | +77.6% | 0.00% | – |
| Q3 2014 | $570,000 | +0.9% | 136,632 | +11.7% | 0.00% | – |
| Q2 2014 | $565,000 | -77.1% | 122,335 | -77.5% | 0.00% | -100.0% |
| Q1 2014 | $2,462,000 | +504.9% | 543,483 | +582.6% | 0.00% | – |
| Q4 2013 | $407,000 | -50.8% | 79,620 | -69.7% | 0.00% | – |
| Q3 2013 | $827,000 | +1192.2% | 262,479 | +734.3% | 0.00% | – |
| Q2 2013 | $64,000 | -98.5% | 31,460 | -98.6% | 0.00% | -100.0% |
| Q4 2012 | $4,166,000 | +4151.0% | 2,204,314 | +4782.5% | 0.00% | – |
| Q3 2012 | $98,000 | +34.2% | 45,147 | -3.6% | 0.00% | – |
| Q2 2012 | $73,000 | 0.0% | 46,848 | -18.7% | 0.00% | – |
| Q1 2012 | $73,000 | – | 57,627 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Parametrica Management Ltd | 61,882 | $438,000 | 2.76% |
| BB BIOTECH AG | 8,330,000 | $58,893,000 | 1.87% |
| Cormorant Asset Management, LP | 1,600,000 | $11,312,000 | 1.81% |
| HARVEY CAPITAL MANAGEMENT INC | 623,950 | $4,411,000 | 1.76% |
| WILLIAM HARRIS INVESTORS INC | 488,666 | $3,455,000 | 0.98% |
| Eventide Asset Management | 2,097,500 | $14,829,000 | 0.86% |
| AWM Investment Company, Inc. | 400,000 | $2,828,000 | 0.55% |
| NORTHPOINTE CAPITAL LLC | 507,344 | $3,587,000 | 0.47% |
| Rock Springs Capital Management LP | 715,000 | $5,055,000 | 0.41% |
| Opus Point Partners Management, LLC | 100,000 | $707,000 | 0.39% |